Crawford Investment Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14M | Sell |
126,453
-22,943
| -15% | -$2.54M | 0.24% | 89 |
|
2025
Q1 | $16.7M | Sell |
149,396
-175,441
| -54% | -$19.7M | 0.3% | 80 |
|
2024
Q4 | $30M | Sell |
324,837
-14,156
| -4% | -$1.31M | 0.54% | 49 |
|
2024
Q3 | $28.4M | Sell |
338,993
-4,761
| -1% | -$399K | 0.49% | 55 |
|
2024
Q2 | $23.6M | Buy |
343,754
+15,699
| +5% | +$1.08M | 0.45% | 59 |
|
2024
Q1 | $24M | Buy |
328,055
+3,633
| +1% | +$266K | 0.45% | 60 |
|
2023
Q4 | $26.3M | Sell |
324,422
-48,843
| -13% | -$3.96M | 0.53% | 52 |
|
2023
Q3 | $28M | Buy |
373,265
+3,146
| +0.8% | +$236K | 0.61% | 47 |
|
2023
Q2 | $28.5M | Buy |
370,119
+75,284
| +26% | +$5.8M | 0.58% | 47 |
|
2023
Q1 | $24.5M | Sell |
294,835
-29,933
| -9% | -$2.48M | 0.52% | 54 |
|
2022
Q4 | $27.9M | Sell |
324,768
-21,165
| -6% | -$1.82M | 0.6% | 47 |
|
2022
Q3 | $21.3M | Buy |
345,933
+12,672
| +4% | +$782K | 0.5% | 52 |
|
2022
Q2 | $20.6M | Buy |
+333,261
| New | +$20.6M | 0.46% | 56 |
|